Divers pathways mediate δ-opioid receptor down regulation within the same cell

Molecular Brain Research

Volumn 96, Issue 1-2, 2001, Pages 142-150

  Shapira, Ma'anit ^a   Keren, Ora ^a   Gafni, Mikhal ^a   Sarne, Yosef ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

G protein coupled receptor; Opioid receptors; Phosphorylation; Receptor down regulation; Receptor internalization

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHLOROQUINE; CLATHRIN; DELTA OPIATE RECEPTOR; DIPRENORPHINE; ETORPHINE; G PROTEIN COUPLED RECEPTOR KINASE; GENISTEIN; LACTACYSTIN; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE AGONIST; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE; STAUROSPORINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL STRAIN; COATED PIT; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; INTERNALIZATION; LIGAND BINDING; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM;

ACETYLCYSTEINE; ANALGESICS, OPIOID; ANIMALS; ANTIRHEUMATIC AGENTS; CHLOROQUINE; CYSTEINE PROTEINASE INHIBITORS; DIPRENORPHINE; DOWN-REGULATION; ETORPHINE; FLAVONOIDS; GENISTEIN; GTP-BINDING PROTEINS; HUMANS; KIDNEY; MAP KINASE SIGNALING SYSTEM; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; PHOSPHORYLATION; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, DELTA; STAUROSPORINE; TEPROTIDE; TRANSFECTION; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0035976757     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00283-2     Document Type: Article

References (44)

1. Isolation and expression of a mouse CB1 cannabinoid receptor gene - Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells
2. Molecular cloning and expression of a delta-opioid receptor from rat-brain
3. Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the mu-opioid receptor
4. High-efficiency transformation of mammalian cells by plasmid DNA
5. Delta and kappa-opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist
6. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity
7. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation
8. The absence of a direct correlation between the loss of [D-Ala2, MePhe4,Gly5-ol] enkephalin inhibition of adenylyl cyclase activity and agonist-induced mu-opioid receptor phosphorylation
9. Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta2-adrenergic receptor
10. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells
11. Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism
12. Desensitization of the delta-opioid receptor correlates with its phosphorylation in SK-N-BE cells: Involvement of a G protein-coupled receptor kinase
13. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation
14. Effect of G protein-coupled receptor kinase 2 on the sensitivity of M4 muscarinic acetylcholine receptors to agonist-induced internalization and desensitization in NG108-15 cells
15. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5
16. Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis
17. Mu-opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain
18. Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure
19. Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization
20. Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase
21. Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization
22. Mutation of tyrosine 318 (Y318F) in the delta-opioid receptor attenuates tyrosine phosphorylation, agonist-dependent receptor internalization, and mitogen-activated protein kinase activation
23. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC
24. Demonstration and characterization of a stereospecific opiate receptor in the neuroblastoma N18TG2 cells
25. Opiate receptor down-regulation and desensitization in neuroblastoma×glioma NG108-15 hybrid cells are two separate cellular adaptation processes
26. Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes
27. Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor
28. Mechanisms of beta-adrenergic receptor desensitization and resensitization
29. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: Internalization is required for down-regulation
30. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism - Kappa receptor internalization is not required for mitogen-activated protein kinase activation
31. Methadone-induced desensitization of the delta-opioid receptor is mediated by uncoupling of receptor from G protein
32. Phosphorylation is not required for dynamin-dependent endocytosis of a truncated mutant opioid receptor
33. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor - The receptor is a direct substrate for protein-tyrosine kinase
34. A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization
35. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles
36. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells
37. Long-term regulation of opioid receptors in neuroblastoma and lymphoma cell lines
38. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors
39. Role for C-tail residues in delta opioid receptor downregulation
40. Sequestration of the delta opioid receptor - Role of the C terminus in agonist-mediated internalization
41. Down-regulation of G protein-coupled receptors
42. Internalization and down-regulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein-coupled receptor kinase 2
43. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness
44. Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin